The wildcard symbol (*) can be used in place of letters or characters in query words to search for different permutations of a word.
* Can be in any position in the term and matches any number of characters.
For example: te*t matches text and test
Search terms can be a single word or several words.
Quotes can be used to search for phrases.
For example: "tissue assay"
The following boolean connectors can be used: AND, OR, NOT
TEST CHANGE effective
Click to view changes
Some features of the Laboratory Test Directory may not be available; to take advantage of all features,
please upgrade your browser. For more information, visit our
browser page.
Test intended for patients age 40-80. Stratifies risk of aggressive prostate cancer in patients with elevated PSA where biopsy is being considered. Test should not be ordered if (1) prostate cancer was previously diagnosed; (2) digital rectal exam was performed within the last 4 days; (3) any procedure or therapy was used to treat symptomatic benign prostatic hyperplasia (BPH) within the past 6 months; (4) any invasive, urologic procedure that may be associated with a secondary PSA evaluation was done within the past 6 months; (5) 5-alpha reductase inhibitor (5-ARI) therapy, such as Avodart (dutasteride) or Proscar (finasteride), was administered within the past 6 months.
4 Kallikrein Biomarkers: Total PSA, Free PSA, percent free PSA, Intact PSA and hK2. Test should not be ordered if Digital Rectal Exam (DRE) has been performed within the last 4 days or if biopsy history is positive.
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.